Utility of Standard Hemostasis Tests for Diagnosing Hypercoagulability

Avin Arjoonsingh, DVM, MS, DACVIM (SAIM), University of the West Indies, Kingston, Jamaica

ArticleLast Updated October 20242 min read
image source

In the Literature

Clarkin-Breslin RC, Chalifoux NV, Buriko Y. Standard tests of haemostasis do not predict elevated thromboelastographic maximum amplitude, an index of hypercoagulability, in sick dogs. J Small Anim Pract. 2024. doi:10.1111/jsap.13741


The Research …

Standard hemostasis tests (eg, prothrombin time [PT], activated partial thromboplastin time [aPTT]) are used to determine hypocoagulability, but their utility for determining hypercoagulability is unclear.1 Viscoelastic testing (eg, thromboelastography [TEG]) reflects clot formation, strength, and lysis and has been proposed as a more useful tool for determining hypocoagulable and hypercoagulable states.2-4

This prospective case-control study compared PT, aPTT, and D-dimers in sick dogs (n = 71) with hypercoagulable and normocoagulable states confirmed by TEG. Packed-cell volume (PCV) and platelet counts (confirmed via manual blood smear) were also measured. Of all dogs, 51% were hypercoagulable and 49% were normocoagulable based on TEG tracings. A wide range of diseases was represented. No correlation was found between standard tests of hemostasis (ie, PT, aPTT, D-dimers) and TEG; however, lower PCV and higher platelet counts were significantly associated with hypercoagulability, a finding that has been previously reported.5,6


… The Takeaways

Key pearls to put into practice:

  • PT and aPTT are not useful for diagnosing hypercoagulable states in dogs. Although several studies in human medicine and a single study in veterinary medicine show these tests may have some utility, there is not enough evidence to support their use in veterinary medicine.7-10 PT and aPTT are useful for assessing bleeding tendencies and response to anticoagulant drug therapies (eg, factor Xa inhibitors, low molecular weight heparin), even though reference intervals have not been established.11

  • Viscoelastic testing can be used for prothrombotic and bleeding disorders because it provides an overall assessment of coagulation but cannot be relied on as a standalone test. Gold standards for diagnosing coagulation disorders in dogs are not available; viscoelastic test results should thus be evaluated alongside clinical presentation, disease process, and other test results (eg, PCV, platelet count) to determine whether treatment is needed.

  • Prothrombotic states can occur with a wide range of disease processes. Benefits of preventing thrombosis should be weighed against risk for bleeding when selecting treatment.